Wolverine Asset Management LLC Exelixis, Inc. Call Options Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 15, 2019
SELL
$19.6 - $24.76 $94,080 - $118,848
-4,800 Reduced 20.96%
18,100 $430,000
Q4 2018

Feb 14, 2019
SELL
$13.65 - $21.8 $1.73 Million - $2.77 Million
-127,100 Reduced 84.73%
22,900 $450,000
Q3 2018

Nov 14, 2018
BUY
$15.87 - $22.4 $2.38 Million - $3.36 Million
150,000 New
150,000 $2.66 Million

Others Institutions Holding EXEL

# of Institutions
503
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email